‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
www.theguardian.com
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
What it costs to make vs what they charge at the pharmacy are two very, very different numbers.
Yeah, but then you have packaging costs, and distribution costs, and marketing costs, and shareholder dividends, and CEO bonuses, and AI integration, and lobbying costs....
So really, we're practically losing money at a $450/month subscription.
$450/mo. would be a bargain. They'll be squeezing them for hundreds of thousands a year.
Governments can set the price like they did with insulin, or just nationalize production and sell it themselves.